|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Jan 31, 2020
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||
| CURRENT ASSETS | |||||||||||||||
| Cash | |||||||||||||||
| Trade receivables, net | |||||||||||||||
| Loan receivables, net | |||||||||||||||
| Interest receivables | |||||||||||||||
| Other receivables, prepayments and deposits, net | |||||||||||||||
| Total current assets | |||||||||||||||
| NON-CURRENT ASSETS | |||||||||||||||
| Property, plant and equipment, net | |||||||||||||||
| Operating lease right-of-use assets, net | |||||||||||||||
| Intangible assets, net | |||||||||||||||
| Long-term loan receivables, net | |||||||||||||||
| Long-term investments, net | |||||||||||||||
| Goodwill | |||||||||||||||
| Total non-current assets | |||||||||||||||
| Total assets | |||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||||||||
| CURRENT LIABILITIES | |||||||||||||||
| Amount due to a shareholder | |||||||||||||||
| Accounts payable | |||||||||||||||
| Other payables and accrued liabilities | |||||||||||||||
| Deferred Revenue | |||||||||||||||
| Operating lease liability, current | |||||||||||||||
| Customer deposits | |||||||||||||||
| Taxes payable | |||||||||||||||
| Total current liabilities | |||||||||||||||
| LONG-TERM LIABILITIES | |||||||||||||||
| Operating lease liability, non-current | |||||||||||||||
| Non-current Deferred tax liabilities | |||||||||||||||
| Total non-current liabilities | |||||||||||||||
| Total liabilities | |||||||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||||||
| Ordinary shares, $0.004 par value, 500,000,000 shares authorized, 122,160,166 and 112,510,166 issued and outstanding as of December 31, 2025 and 2024, respectively | |||||||||||||||
| Additional paid-in-capital | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||
| Total shareholders' equity | |||||||||||||||
| Total liabilities and shareholders' equity | |||||||||||||||
Loading...